Leaflet ERTAPENEM APTAPHARMA 1g powder for concentrate infusion solution


Indicated for: bacterial infections

Route of administration: infusion

Substance: ertapenem (carbapenem antibiotic)

ATC: J01DH03 (Antiinfectives for systemic use | Other beta-lactam antibacterials | Carbapenems)

Ertapenem is an antibiotic from the carbapenem class, used to treat severe bacterial infections such as abdominal, urinary tract, skin, or lung infections. It works by destroying the bacteria that cause the infection and is effective against a wide range of germs.

Ertapenem is administered by intravenous or intramuscular injection, according to the doctor's instructions. The dose and duration of treatment are determined individually, depending on the type and severity of the infection.

Side effects may include diarrhea, nausea, injection site reactions, headaches, or, rarely, severe allergic reactions. Medical monitoring is necessary throughout the treatment to prevent complications.

Ertapenem is an important option for the treatment of severe infections, especially when other antibiotics are not effective, helping to ensure rapid recovery and prevent complications.

General data about ERTAPENEM APTAPHARMA 1g

  • Substance: ertapenem
  • Date of last drug list: 01-04-2024
  • Commercial code: W68535002
  • Concentration: 1g
  • Pharmaceutical form: powder for concentrate infusion solution
  • Quantity: 10
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: ACS DOBFAR S.P.A. - ITALIA
  • Holder: APTA MEDICA INTERNACIONAL D.O.O. - SLOVACIA
  • Number: 14257/2022/02
  • Shelf life: 2 years